Lauren Fackler
Physician Assistant · Staunton, VANPI 1730733429
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 828 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 828 payments — averaging $14.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Johnson & Johnson$1K
- Lundbeck LLC$954
- Alkermes, Inc.$923
- plus $4K from 24 others
What the payments were for
- Food & beverage$11,97899%
- Education$1561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 136 | $2,106 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 157 | $1,652 |
| Otsuka America Pharmaceutical, Inc. | 100 | $1,223 |
| Johnson & Johnson | 50 | $1,017 |
| Lundbeck LLC | 72 | $954 |
| Alkermes, Inc. | 61 | $923 |
| Teva Pharmaceuticals USA, Inc. | 49 | $816 |
| Neurocrine Biosciences, Inc. | 44 | $766 |
| Vanda Pharmaceuticals Inc. | 23 | $516 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $397 |
| Axsome Therapeutics, Inc. | 26 | $219 |
| Corium, LLC | 9 | $210 |
| Noven Therapeutics, LLC | 11 | $166 |
| E.r. Squibb & Sons, L.L.C. | 7 | $149 |
| Sunovion Pharmaceuticals Inc. | 13 | $138 |
| Novo Nordisk | 8 | $134 |
| Supernus Pharmaceuticals, Inc. | 8 | $124 |
| Livanova USA, Inc. | 5 | $89 |
| Ironshore Pharmaceuticals Inc. | 4 | $86 |
| Neuronetics, Inc. | 3 | $81 |
| Eisai Inc. | 3 | $62 |
| Almatica Pharma LLC | 3 | $57 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $49 |
| Avanir Pharmaceuticals, Inc. | 2 | $44 |
| Bausch Health US, LLC | 2 | $42 |
| Indivior Inc. | 2 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Noven Pharmaceuticals, Inc. | 2 | $26 |
| Bioxcel Therapeutics, Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$102
How this compares
$12,135 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 19 | $150,402 |
| RexultiBrexpiprazole | 17 | $25,378 |
| TrintellixVortioxetine Hydrobromide | 14 | $7,640 |
| MydayisDextroamphetamine/Amphetamine | 12 | $3,622 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 25 | $3,573 |
| Fluphenazine Hcl | 21 | $3,143 |
| Vilazodone Hcl | 19 | $1,939 |
| Atomoxetine Hcl | 14 | $1,310 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 40 | $1,296 |
| Hydroxyzine Hcl | 30 | $1,131 |
| Zaleplon | 19 | $1,071 |
| Duloxetine Hcl | 56 | $983 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 69 | $904 |
| Quetiapine Fumarate | 57 | $780 |
| Lurasidone Hcl | 19 | $742 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $766 | $150,40219 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,223 | $25,37817 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $397 | $7,64014 claims |
| Almatica Pharma LLCSertraline Hcl | $57 | $26958 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Staunton
- John CarterStaunton$90K
- Stephanie BrutonStaunton$15K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.